H. Nakashima

发表

Phase I and Pharmacokinetic Study of Paclitaxel by 24‐Hour Intravenous Infusion

K. Eguchi, N. Saijo, Y. Ohe, 1994, Japanese journal of cancer research : Gann.

CPT‐11: Population Pharmacokinetic Model and Estimation of Pharmacokinetics Using the Bayesian Method in Patients with Lung Cancer

K. Eguchi, N. Saijo, Y. Ohe, 1994, Japanese journal of cancer research : Gann.

Efficient Sampling Strategies for Forecasting Pharmacokinetic Parameters of Irinotecan (CPT‐11): Implication for Area Under the Concentration‐Time Curve Monitoring

H. Ohmatsu, K. Eguchi, N. Saijo, 1995, Therapeutic drug monitoring.

Influence of Genetic Polymorphisms and Non-Genetic Factors upon Warfarin Maintenance Dose in Japanese Elderly Patients

H. Nakashima, T. Uno, J. Miura, 2011 .

A Randomized Cross‐over Study of High‐dose Metoclopramide plus Dexamethasone versus Granisetron plus Dexamethasone in Patients Receiving Chemotherapy with High‐dose Cisplatin

H. Ohmatsu, K. Eguchi, N. Saijo, 1994, Japanese journal of cancer research : Gann.

The effect of staggered dosing of sucralfate on oral bioavailability of sparfloxacin.

H. Nakashima, S. Nakano, M. Kamberi, 2002, British journal of clinical pharmacology.

Temporal Variation in the Pharmacokinetics of Gentamicin in Man

H. Nakashima, N. Uemura, S. Matsuki, 1998 .

Assessment of a Simple Method for Acetylator Phenotyping with Caffeine

A. Ebihara, H. Nakashima, M. Hashiguchi, 1990 .

Pharmacokinetics and Pharmacodynamics of a New Transdermal Clonidine, M‐5041T, in Healthy Subjects

A. Fujimura, K. Ohashi, Y. Kumagai, 1993, Journal of clinical pharmacology.

Influence of Application Site of a New Transdermal Clonidine, M‐5041T, on its Pharmacokinetics and Pharmacodynamics in Healthy Subjects

A. Fujimura, K. Ohashi, Y. Kumagai, 1993, Journal of clinical pharmacology.

Chronopharmacokinetic Studies of Pranoprofen and Procainamide

A. Fujimura, Y. Kumagai, A. Ebihara, 1989, Journal of clinical pharmacology.

Phase I and pharmacologic study of 9-aminocamptothecin given by 72-hour infusion in adult cancer patients.

S. Arbuck, C. Takimoto, J. Grem, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pharmacodynamics and pharmacokinetics of a 72-hour infusion of 9-aminocamptothecin in adult cancer patients.

S. Arbuck, C. Takimoto, J. Grem, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Influence of Food on the Absorption of Beta‐Methyldigoxin

H. Nakashima, T. Kotegawa, K. Tsutsumi, 1992, Journal of clinical pharmacology.

[Effects of diltiazem on catecholamine release from cat adrenal glands (author's transl)].

H. Nakashima, A. Kiyomoto, M. Sato, 1981, Nihon yakurigaku zasshi. Folia pharmacologica Japonica.

Comparison of the Pharmacokinetics, Pharmacodynamics, and Safety of Oral (Catapres) and Transdermal (M‐5041T) Clonidine in Healthy Subjects

A. Fujimura, K. Ohashi, Y. Kumagai, 1994, Journal of clinical pharmacology.

Circadian influence on effect of propranolol on exercise-induced tachycardia in healthy subjects

A. Fujimura, K. Ohashi, Y. Kumagai, 2004, European Journal of Clinical Pharmacology.

Chronopharmacological study of bunazosin hydrochloride in healthy subjects.

A. Fujimura, Y. Kumagai, A. Ebihara, 1989, International journal of clinical pharmacology research.

Pharmacokinetics of Beta‐Methyldigoxin in Subjects with Normal and Impaired Renal Function

H. Nakashima, T. Tateishi, K. Tsutsumi, 1993, Journal of clinical pharmacology.

TDM of Digoxin and β-Methyldigoxin

Y. Kumagai, A. Ebihara, H. Nakashima, 1991 .

Clinical Pharmacology of Dilevalol (III). A Pharmacokinetic Study of Dilevalol in Elderly Subjects with Essential Hypertension

A. Fujimura, Y. Kumagai, A. Ebihara, 1989, Journal of clinical pharmacology.

Pharmacokinetics, Pharmacodynamics, and Safety of Bevantolol, a New β1-Selective β-Adrenoceptor Antagonist, in Japanese Healthy Volunteers

A. Fujimura, Y. Kumagai, K. Taniguchi, 1989 .

Clinical Pharmacology of 9‐Aminocamptothecin

J. Grem, C. Allegra, J. M. Hamilton, 1996, Annals of the New York Academy of Sciences.

Different chronotherapeutic effects of valsartan and olmesartan in non-dipper hypertensive patients during valsartan treatment at morning.

S. Ishikawa, A. Fujimura, T. Shiga, 2015, Journal of pharmacological sciences.

Clinical Pharmacology of Ibopamine-(1) Safety and Pharmacological Actions after Single and Multiple Oral Doses in Japanese Healthy Subjects

A. Fujimura, K. Ohashi, Y. Kumagai, 1988 .

Clinical Pharmacology of Ibopamine-(2) Pharmacokinetics after Single and Multiple Oral Administration in Healthy Japanese Subjects

A. Fujimura, K. Ohashi, Y. Kumagai, 1988 .

Effect of Diltiazem on the Reduction in Exercise-induced Tachycardia and Kinetic Parameters of Propranolol or Atenolol

K. Ohashi, Y. Kumagai, A. Ebihara, 1990 .

Effect of diltiazem on the pharmacokinetics of propranolol, metoprolol and atenolol

S. Hosoda, K. Ohashi, Y. Kumagai, 2004, European Journal of Clinical Pharmacology.